search
Back to results

Biomedical HIV/AIDS Prevention Program Yunnan (B-HAPPY)

Primary Purpose

HIV/AIDS

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Enhanced implementation of PrEP
Sponsored by
Columbia University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for HIV/AIDS focused on measuring HIV prevention, Implementation science, Pre-Exposure Prophylaxis, Men who have sex with men, China

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleAccepts Healthy Volunteers

This study will recruit two types of study participants: A. MSM clients at study sites; B. study staff who will be involved in the implementation of this project.

A. MSM clients:

Inclusion criteria:

Clients at study sites (VCT or STI [sexually transmitted infections] clinics) are eligible for inclusion in the study if they meet all of the following criteria:

  • Aged 18 years or older
  • Male sex at birth
  • Willing and able to provide written consent form
  • Able and willing to provide finger-scan and contact information
  • Not infected with HIV-1
  • Any male sex partner in past 12 months

Exclusion Criteria:

Clients at study sites (VCT or STI clinics) will be excluded from the study if they meet any of the following criteria:

  • Diagnosed with HIV or AIDS
  • Signs or symptoms of acute HIV infection
  • Unable to provide inform consent
  • At enrollment, has any medical, psychological, or social condition that, in the opinion of the investigator, would jeopardize the health or wellbeing of the participant during the study or the integrity of the data

B. Study staff:

Inclusion criteria:

Staff at study sites (VCT or STI clinics) are eligible for inclusion in the study if they meet all of the following criteria:

  • Aged 18 years or older
  • Employed at site for at least 3 months
  • Willing and able to provide consent

Exclusion criteria:

Staff at study sites (VCT or STI clinics) will be excluded from the study if they meet any of the following criteria:

  • Unable to provide consent
  • At enrollment, has any medical, psychological, or social condition that, in the opinion of the investigator, would jeopardize the health or wellbeing of the participant during the study or the integrity of the data

Sites / Locations

  • Yunnan Center for Disease Prevention and ControlRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Standard implementation

Enhanced implementation

Arm Description

During Standard Implementation, sites will use standard Yunnan Center for Disease Control and Prevention strategies to introduce HIV prevention innovations.

During Enhanced Implementation, sites will transition to receive enhanced Implementation Support to plan and implement PrEP.

Outcomes

Primary Outcome Measures

PrEP awareness
Number of clients who are aware of PrEP
PrEP eligible
Number of clients who are eligible for PrEP
PrEP offer
Number of clients who are offered PrEP
PrEP initiation
Number of clients initiating PrEP
PrEP continuation
Number of PrEP initiators who remain PrEP-eligible and sustain use at six months
Proportion of PrEP implementation activities completed
The SIC is an 8-stage observational assessment tool recording organizational site completion of implementation activities that map onto the three phases of implementation (Pre-Implementation, Implementation, Sustainability). Proportion of PrEP implementation activities completed will be measured.
Time to completion for each implementation phase
The SIC is an 8-stage observational assessment tool recording organizational site completion of implementation activities that map onto the three phases of implementation (Pre-Implementation, Implementation, Sustainability). Time to completion of each implementation phase will be measured.
Cost and resource allocation for completion of each implementation phase
Costs and resource allocation for completion of each implementation phase will be measured with the Cost of Implementing New Strategies (COINS) tool.

Secondary Outcome Measures

Full Information

First Posted
June 18, 2019
Last Updated
April 25, 2022
Sponsor
Columbia University
Collaborators
Yunnan Center for Disease Control and Prevention, Oregon Social Learning Center, Hunter College of The City University of New York, National Institute of Mental Health (NIMH)
search

1. Study Identification

Unique Protocol Identification Number
NCT03992274
Brief Title
Biomedical HIV/AIDS Prevention Program Yunnan
Acronym
B-HAPPY
Official Title
Yunnan-ADARC HIV Prevention Program: Developing and Testing a Model to Implement and Sustain PrEP Delivery in China
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Recruiting
Study Start Date
August 1, 2020 (Actual)
Primary Completion Date
April 2024 (Anticipated)
Study Completion Date
October 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Columbia University
Collaborators
Yunnan Center for Disease Control and Prevention, Oregon Social Learning Center, Hunter College of The City University of New York, National Institute of Mental Health (NIMH)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
B-HAPPY is an implementation project to study the process by which pre-exposure prophylaxis (PrEP) is introduced and integrated into a specific international health system facing high rates of HIV incidence among men who have sex with men. The study will use a stepped wedge design to compare implementation outcomes across eight municipalities in Yunnan, China.
Detailed Description
B-HAPPY is an implementation science project that will introduce and evaluate the implementation of PrEP among over 1000 men who have sex with men (MSM), in eight municipalities in Yunnan, China. The project aims to compare the effectiveness of two implementation strategy bundles: 1) Standard Implementation: comprising the strategies that the Yunnan Center for Disease Control and Prevention would usually use to introduce HIV prevention innovations in the absence of the proposed study; and 2) Enhanced Implementation: standard implementation enhanced by a SIC-guided approach to plan and implement PrEP. This study will use a stepped-wedge design, where sites will go through four study periods: a Pre-Baseline Period (Routine Service with no PrEP Implementation), a Baseline Period (Standard Implementation of PrEP), an Experiment Period (Enhanced Implementation of PrEP), and a Post-Experiment-Observation Period. Sites are randomized to the timing of the intervention initiation, with 2 sites moving from Standard Implementation to Enhanced Implementation every 6 months. The intervention condition changes over time and the intervention effect is the difference in outcomes between the Baseline and Experiment Periods, and the Post-Experiment and Baseline Periods. The specific aims of the proposed study are: To evaluate whether the addition of SIC-guided PrEP delivery (Enhanced Implementation) to standard health system PrEP delivery improves services outcomes. Through a stepped-wedge randomized trial across eight Yunnan municipalities, within site change over time will be examined; timing of introduction of Enhanced Implementation will be randomized across four cohorts of two sites each. Client-services outcomes include progress to achieving the "Five-80s" (patient PrEP awareness, screening, offering, initiation, continuation). To examine the implementation process and efficiency of the Enhanced versus Standard implementation approaches. Using the Stages of Implementation Completion (SIC) and Cost of Implementing New Strategies (COINS) tools, sites will be monitored for implementation process and resource use. Outcomes will include proportion of implementation activities completed; duration of each implementation phase; and cost and resource allocation for completion of each implementation phase.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV/AIDS
Keywords
HIV prevention, Implementation science, Pre-Exposure Prophylaxis, Men who have sex with men, China

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
352 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard implementation
Arm Type
No Intervention
Arm Description
During Standard Implementation, sites will use standard Yunnan Center for Disease Control and Prevention strategies to introduce HIV prevention innovations.
Arm Title
Enhanced implementation
Arm Type
Experimental
Arm Description
During Enhanced Implementation, sites will transition to receive enhanced Implementation Support to plan and implement PrEP.
Intervention Type
Other
Intervention Name(s)
Enhanced implementation of PrEP
Intervention Description
During Enhanced Implementation study sites will receive Implementation Support to plan and introduce PrEP by following the eight stages of the PrEP-adapted SIC. Implementation Support specifically will involve a centralized technical assistance system developed using US-based PrEP experience focused on addressing implementation issues identified through real-time analysis of client, clinic, and implementation data.
Primary Outcome Measure Information:
Title
PrEP awareness
Description
Number of clients who are aware of PrEP
Time Frame
Up to 48 months
Title
PrEP eligible
Description
Number of clients who are eligible for PrEP
Time Frame
Up to 48 months
Title
PrEP offer
Description
Number of clients who are offered PrEP
Time Frame
Up to 48 months
Title
PrEP initiation
Description
Number of clients initiating PrEP
Time Frame
Up to 48 months
Title
PrEP continuation
Description
Number of PrEP initiators who remain PrEP-eligible and sustain use at six months
Time Frame
Up to 48 months
Title
Proportion of PrEP implementation activities completed
Description
The SIC is an 8-stage observational assessment tool recording organizational site completion of implementation activities that map onto the three phases of implementation (Pre-Implementation, Implementation, Sustainability). Proportion of PrEP implementation activities completed will be measured.
Time Frame
Up to 48 months
Title
Time to completion for each implementation phase
Description
The SIC is an 8-stage observational assessment tool recording organizational site completion of implementation activities that map onto the three phases of implementation (Pre-Implementation, Implementation, Sustainability). Time to completion of each implementation phase will be measured.
Time Frame
Up to 48 months
Title
Cost and resource allocation for completion of each implementation phase
Description
Costs and resource allocation for completion of each implementation phase will be measured with the Cost of Implementing New Strategies (COINS) tool.
Time Frame
Up to 48 months

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
This study will recruit two types of study participants: A. MSM clients at study sites; B. study staff who will be involved in the implementation of this project. A. MSM clients: Inclusion criteria: Clients at study sites (VCT or STI [sexually transmitted infections] clinics) are eligible for inclusion in the study if they meet all of the following criteria: Aged 18 years or older Male sex at birth Willing and able to provide written consent form Able and willing to provide finger-scan and contact information Not infected with HIV-1 Any male sex partner in past 12 months Exclusion Criteria: Clients at study sites (VCT or STI clinics) will be excluded from the study if they meet any of the following criteria: Diagnosed with HIV or AIDS Signs or symptoms of acute HIV infection Unable to provide inform consent At enrollment, has any medical, psychological, or social condition that, in the opinion of the investigator, would jeopardize the health or wellbeing of the participant during the study or the integrity of the data B. Study staff: Inclusion criteria: Staff at study sites (VCT or STI clinics) are eligible for inclusion in the study if they meet all of the following criteria: Aged 18 years or older Employed at site for at least 3 months Willing and able to provide consent Exclusion criteria: Staff at study sites (VCT or STI clinics) will be excluded from the study if they meet any of the following criteria: Unable to provide consent At enrollment, has any medical, psychological, or social condition that, in the opinion of the investigator, would jeopardize the health or wellbeing of the participant during the study or the integrity of the data
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kathrine Meyers, DrPH,MPP,MSc
Phone
2123046110
Email
kam2157@cumc.columbia.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kathrine Meyers, DrPH,MPP,MSc
Organizational Affiliation
Aaron Diamond AIDS Research Center, Columbia University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Yunnan Center for Disease Prevention and Control
City
Kunming
State/Province
Yunnan
ZIP/Postal Code
650000
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yanling Ma
First Name & Middle Initial & Last Name & Degree
Yanling Ma

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Data from the B-HAPPY project will be available at end of the project by contacting the study PI.

Learn more about this trial

Biomedical HIV/AIDS Prevention Program Yunnan

We'll reach out to this number within 24 hrs